全球横向流动化验市场：依产品类型、应用、技术、最终用户、地区分類的规模与趋势、COVID-19 影响分析、2030 年预测

横向流动化验(LFA)，也称为横向流动免疫色谱分析，是医疗设备。横向流动化验市场涉及横向流动检测套组、试剂、组件、相关设备和产品的开发、製造和分销，涉及医疗保健、製药、食品安全、环境检测和动物诊断等多个行业和应用。在许多诊所和医院中，尤其是在最近的疫情之后，由于感染疾病的增加、对就地检验（POCT）的需求增加，以及人们对 COVID-19 疫情后感染预防和控制重要性的认识不断提高，LFA 的采用有所增加。预计 2024 年全球横向流动化验市场规模为 100.1 亿美元，到 2030 年将达到 154.2 亿美元。

全球横向流动化验市场呈现持续成长，这主要得益于发展中国家和已开发国家患有感染疾病和慢性病的患者数量的增加。老年人口的不断扩大、对预防性医疗保健的日益重视、自我管理疾病理念的日益普及、居家医疗套件需求的激增、新兴经济体医疗保健基础设施的快速扩张以及家庭诊断套件的高消费量预计将继续推动全球横向流动化验市场的需求。此外，透过横向流动化验促进的POCT使诊断更贴近患者，改善了偏远和服务不足地区获得医疗服务的机会，这些地区传统检测设施有限，为患者提供及时的诊断和治疗，特别是对于紧急情况和需要即时救助的疾病。因此，随着就地检验的日益普及以及越来越多的公司专注于开发基于创新横向流动化验的 POC 设备，基于横向流动化验的照护现场(POC) 测试有望取代耗时的传统测试方法，从而在预测期内促进全球横向流动化验市场的成长。预计 2025-2030 年预测期内市场复合年增长率为 7.46%。

本报告对全球横向流动化验市场进行了深入分析，包括市场动态、COVID-19 的影响和竞争格局。

目录

第一章执行摘要

第 2 章 简介

• 横向流动化验：概述
  • 横向流动化验的定义
  • 横向流动化验的优势
• 横向流动化验市场细分
  • 横向流动化验市场细分

第三章 全球市场分析

• 全球横向流动化验市场：分析
  • 全球横向流动化验市场概况
  • 全球横向流动化验市场规模
  • 全球横向流动化验市场依产品类型划分（套件/试剂、侧向流读取仪）
  • 全球横向流动化验市场按应用划分（临床测试、兽医诊断、食品安全和环境测试、药物开发和品质测试）
  • 全球横向流动化验市场依技术划分（夹层分析、竞争性分析、多重侦测分析）
  • 全球横向流动化验市场按最终用户（医院和诊所、诊断实验室、居家照护、製药和生物技术公司等）划分
  • 横向流动化验市场按地区划分（北美、欧洲、亚太地区、世界其他地区）
• 全球横向流动化验市场：产品类型分析
  • 全球横向流动化验市场概览（依产品类型）
  • 横向流动化验套件和试剂的全球市场规模
  • 全球横向流动化验领先市场规模
• 全球横向流动化验市场：应用分析
  • 全球横向流动化验市场概览（按应用）
  • 临床测试横向流动化验的全球市场规模
  • 动物医学诊断横向流动化验的全球市场规模
  • 食品安全与环境侦测横向流动化验的全球市场规模
  • 用于药物开发和品质测试的横向流动化验的全球市场规模
• 全球横向流动化验市场：技术分析
  • 全球横向流动化验市场概览（按技术）
  • 全球夹层横向流动化验市场规模
  • 全球竞争性横向流动化验市场规模
  • 全球多重侦测横向流动化验市场规模
• 全球横向流动化验市场：最终用户分析
  • 全球横向流动化验市场：最终用户概览
  • 医院和诊所横向流动化验的全球市场规模
  • 诊断实验室横向流动化验的全球市场规模
  • 全球居家照护横向流动化验市场规模
  • 製药和生物技术公司横向流动化验的全球市场规模
  • 全球其他横向流动化验市场规模

第四章 区域市场分析

• 北美横向流动化验市场：分析
  • 北美横向流动化验市场概览
  • 北美横向流动化验市场规模
  • 北美横向流动化验市场按产品类型划分（套件/试剂、侧向流读取仪）
  • 北美横向流动化验市场依技术划分（夹层侦测、竞争性侦测、多重侦测）
  • 北美横向流动化验市场各地区分布（美国、加拿大、墨西哥）
  • 美国横向流动化验市场规模
  • 加拿大横向流动化验市场规模
  • 墨西哥横向流动化验市场规模
• 欧洲横向流动化验市场：分析
  • 欧洲横向流动化验市场概况
  • 欧洲横向流动化验市场规模
  • 欧洲横向流动化验市场依地区划分（德国、法国、英国、义大利、西班牙、欧洲其他地区）
  • 德国横向流动化验市场规模
  • 英国横向流动化验市场规模
  • 法国横向流动化验市场规模
  • 义大利横向流动化验市场规模
  • 西班牙横向流动化验市场规模
  • 其他欧洲横向流动化验市场规模
• 亚太横向流动化验市场：分析
  • 亚太地区横向流动化验市场概览
  • 亚太地区横向流动化验市场规模
  • 亚太地区横向流动化验市场（按地区划分）（中国、日本、印度、韩国、澳洲、亚太其他地区）
  • 中国横向流动化验市场规模
  • 日本横向流动化验市场规模
  • 印度横向流动化验市场规模
  • 韩国横向流动化验市场规模
  • 澳洲横向流动化验市场规模
  • 其他亚太地区横向流动化验市场规模
• 世界其他地区横向流动化验市场分析
  • 世界其他地区横向流动化验市场概况
  • 其他地区的横向流动化验市场规模

第五章 新冠肺炎疫情的影响

• COVID-19 对横向流动化验市场的影响
• COVID-19 对横向流动化验市场的影响

第六章 市场动态

• 成长动力
  • 老化
  • 感染疾病增加
  • 家庭检测试剂套件和设备的使用日益增多
  • 就地检验正变得越来越流行
• 任务
  • 由于诊断结果缺乏一致性，监管要求严格
  • 来自替代诊断技术的竞争日益激烈
• 市场趋势
  • 人工智慧与生物感测器的融合日益加深
  • 数位科技日益融合
  • 横向横向流动化验的新应用
  • 对个人化和客横向流动化验的需求日益增加

第七章 竞争格局

• 全球横向流动化验市场：竞争格局

第八章 公司简介

• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Merck KGaA (MilliporeSigma)
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson and Company (BD Biosciences)
• QuidelOrtho Corporation (Quidel Corporation)
• Access Bio, Inc.
• PerkinElmer, Inc.

Lateral flow assays (LFA), also known as lateral flow immunochromatographic assays, is a medical device used to detect presence (or absence) of a target analyte in a sample (matrix). Lateral flow assay market is associated with development, manufacturing, and distribution of lateral flow test kits, reagents, components, and related equipment and products across various industries and applications, including healthcare, pharmaceuticals, food safety, environmental testing, veterinary diagnostics, etc. Due to increasing incidences of infectious diseases, rising demand for point-of-care testing (POCT), and increasing awareness about the importance of infection prevention & control after COVID-19 pandemic, there has been increasing adoption of LFAs by many clinics and hospitals, especially after recent pandemic. The global lateral flow assay market value stood at US$10.01 billion in 2024, and is expected to reach US$15.42 billion by 2030.

Global lateral flow assay market demonstrated a consistent growth, primarily driven by rising cases of infectious and chronic diseases in both developing and developed countries. Growing elderly population, increased focus on preventive healthcare, increasing adoption of the concept of self-management of person's medical conditions, surge in the demand for home based medical kits, rapidly expanding healthcare infrastructure in developing economies, and high consumption of home-based diagnostic kits, will continue to boost the demand of global lateral flow assay market. Moreover, POCT, facilitated by lateral flow assays, has brought diagnostics more closer to the patient in the form of improved accessibility to healthcare in remote or underserved areas where access to traditional laboratory facilities may be limited, providing individuals with timely diagnoses and treatment, particularly in emergency situations and for diseases that require immediate assistance. Therefore, with rising popularity of point-of-care testing and increasing number of companies focusing on developing innovative lateral flow assay-based POC devices, point-of-care (POC) tests based of lateral flow assay will continue to replace lengthy and conventional laboratory procedures, augmenting the growth of global lateral flow assay market in the forecasted period. The market is expected to grow at a CAGR of 7.46% over the projected period of 2025-2030.

Market Segmentation Analysis:

By Product Type: The report provides the bifurcation of the lateral flow assay market into two segments based on product type: kits and reagents, and lateral flow readers. Kits & reagents lateral flow assay is the largest segment of global lateral flow assay market owing to rising adoption of lateral flow tests in home care settings, ongoing development of cost effective and user friendly diagnostic kits, ongoing launch of new kits by major players in the market, increasing popularity of self-diagnosis, and rising application of kits and reagents in diagnostic testing of diseases, contaminants & allergens in food products, and environmental testing. Lateral flow assay readers is the fastest growing segment of global lateral flow assay market owing to constant advancements in reader technology, rising demand for portable and easy to use diagnostic devices, ongoing integration of smartphones and mobile applications with lateral flow readers for diagnostic testing, and increasing adoption of lateral flow assays in various fields such as clinical diagnostics, food safety testing, & environmental monitoring.

By Application: The report provides the bifurcation of the lateral flow assay market into four segments on the basis of application: clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. Clinical testing lateral flow assay market is the largest segment of global lateral flow assay market owing to growing patient population suffering from chronic diseases, rapidly expanding healthcare infrastructure in emerging economies, increase in the occurrence of infectious diseases, expanding geriatric population base, noninvasive nature of collecting specimen, growth in number of government initiatives promoting health awareness, and frequent employment of lateral flow assays in clinical laboratories, hospitals, & physician's office for quantitative & qualitative identification of specific antibodies, products of gene amplification, and antigens.

By Technology: The report provides the bifurcation of the lateral flow assay market into three segments on the basis of technology: sandwich assays, competitive assays, and multiplex detection assays. Sandwich lateral flow assay is the largest segment of global lateral flow assay market, owing to rising demand for point-of-care testing and home healthcare diagnostic devices, evolving applications of sandwich assays in medical testing settings, rising government approvals of lateral flow assay rapid detection kits based on the sandwich assay technique, increasing demand for sandwich assays in research and drug discovery applications, and better assay sensitivity & specificity provided by sandwich assays for the measurement of critical and larger analytes.

By End User: The report provides the bifurcation of the lateral flow assay market into five segments on the basis of end user: hospitals and clinics, diagnostic laboratories, home care, pharmaceutical & biotechnology companies, and others. Pharmaceutical & biotechnology companies lateral flow assay is the fastest growing segment, as a result of rising number of infectious diseases and research activities, increasing number of pharmaceutical companies putting extensive efforts in producing effective medicines & vaccines, growing demand for rapid and accurate diagnostic tests for drug development and quality testing, and increasing number of emerging market participants engaged in strategic efforts like mergers and acquisitions, product research, product approvals & launches to improve their lateral flow test products.

By Region: The report provides insight into lateral flow assay market based on the regions namely, Europe, North America, Asia Pacific, and rest of the world. North America is the largest region of global lateral flow assay market, owing to region's well-established healthcare and pharmaceutical sector, high per capita income, increasing prevalence of infectious diseases such as Lyme disease and tuberculosis, ongoing technological advancements and product innovations in the market, rising demand for point-of-care testing, increasing availability of lateral flow tests on online pharmacy platforms, and presence of a significant number of market players in the region including Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., etc.

Asia Pacific is the fastest growing region in the global lateral flow assay market, owing to region's vast population of low and middle-income countries being exposed to multiple infectious diseases, increasing public healthcare expenditure across APAC countries, region's large potential consumer base, expanding geriatric population, growing demand for rapid point-of-care testing, rising public health awareness campaigns, and rapidly developing lateral flow assay components & raw material manufacturing industry in India and China.

Market Dynamics:

Growth Drivers: The global lateral flow assay market has been rapidly growing over the past few years, due to factors such as aging population, rising cases of infectious diseases, growing adoption of home based assay kits and devices, rising popularity of point-of-care testing, etc. There has been an increase in the demand for rapid lateral flow assay diagnostic tests needed to accurately diagnose & monitor medical conditions associated with age-related diseases such as cystic fibrosis, cardiovascular ailments, hepatitis, diabetes, and certain types of cancer, etc., that are frequently caused by age-related physiological changes and metabolic problems. Lateral flow assay testing solutions offers convenience and accessibility to elderly patients that have mobility limitations by assisting them in managing and monitoring chronic condition, as well as allowing healthcare providers to assess the effectiveness of treatments through regular monitoring using lateral assay tests & make necessary medication adjustments. Therefore, the growing elderly population and rising patient pool for chronic illnesses will continue to create a positive demand for lateral flow tests and related products.

Challenges: However, the market growth would be negatively impacted by various challenges such as strict regulatory requirements due to inconsistent diagnostic results, and increased competition from alternative diagnostics technologies. The lateral flow assay kits are prone to depicting false results that can lead to false or no diagnosis, severely affecting patient's health. Therefore, lack of standardization, stringent regulatory requirements, & presence of lengthy approval procedures in industrialized nations is expected to negatively impact the growth of global lateral flow assay market.

Trends: The market is projected to grow at a fast pace during the forecasted period, due to increasing integration of artificial intelligence (AI) and biosensors, rising digital technology integration, evolving newer applications of lateral flow assays, rising demand for personalized and customized lateral flow assays, etc. Lateral flow assay testing has been widely used for infectious disease diagnosis, heart disease diagnosis, veterinary applications, and so on, however, in recent years, there has been an increase in the use of LFA kits and products in several newer applications, such as saliva diagnostics, behavioral health, agriculture (detection of genetically modified organisms and quality control of plants), biological warfare (detection of Bacillus anthracis), environmental testing (detection of contaminating enzymes in production facilities), food microbiology (E. coli Detection of O157, Salmonella, Listeria, and other food spoilage bacteria), etc., which is expected to accelerate the growth of lateral flow assay market in the upcoming years.

Impact Analysis of COVID-19 and Way Forward:

COVID-19 brought in many changes in the world in terms of reduced productivity, loss of life, business closures, closing down of factories and organizations, and shift to an online mode of work. The sudden outbreak of the COVID-19 pandemic was associated with an increase in the demand for simple, rapid, cost-effective, and point-of-care diagnostic devices, such as lateral flow assay kits and readers, needed by hospitals, clinics, airports, schools, and other workplaces for the detection and control of the SARS-CoV-2 virus as LFA test kits demonstrated the ability to detect both symptomatic and asymptomatic COVID-19 infections. The impact of the COVID-19 pandemic on the global lateral flow assay market turned out to be positive, as government organizations and healthcare associations increased their focus on mass population testing, infection prevention & control, and public awareness campaigns aimed at identifying the symptoms and creating patient awareness about the use of lateral flow assay COVID-19 kits.

Competitive Landscape:

The lateral flow assay market is relatively fragmented with increasing number of large and medium sized players accounting for the majority of market revenue. Major companies in the market have been implementing both organic (such as launches, expansion, and product approvals) and inorganic development strategies (such as product launches, partnerships, and collaborations) to expand their product portfolio and gain larger market share. For instance, on August 03, 2023, QuidelOrtho Corporation announced that the company had been granted a De Novo request from the U.S. Food and Drug Administration (FDA), allowing it to market its new Sofia 2 SARS Antigen+ FIA, a lateral flow immunofluorescent assay that is intended for the qualitative detection of the nucleocapsid protein antigen of SARS-CoV-2 in direct anterior nasal swab specimens from individuals with signs and symptoms of upper respiratory infection.

The key players of the lateral flow assay market are:

F. Hoffmann-La Roche Ltd

Siemens Healthineers AG

Thermo Fisher Scientific Inc.

Abbott Laboratories

Merck KGaA (MilliporeSigma)

Bio-Rad Laboratories, Inc.

Becton, Dickinson and Company

QuidelOrtho Corporation (Quidel Corporation)

Access Bio, Inc.

PerkinElmer, Inc.

Table of Contents

1. Executive Summary

2. Introduction

• 2.1 Lateral Flow Assay: An Overview
  • 2.1.1 Definition of Lateral Flow Assay
  • 2.1.2 Benefits of Lateral Flow Assay
• 2.2 Lateral Flow Assay Market Segmentation
  • 2.2.1 Lateral Flow Assay Market Segmentation

3. Global Market Analysis

• 3.1 Global Lateral Flow Assay Market: An Analysis
  • 3.1.1 Global Lateral Flow Assay Market: An Overview
  • 3.1.2 Global Lateral Flow Assay Market by Value
  • 3.1.3 Global Lateral Flow Assay Market by Product Type (Kits and Reagents, and Lateral Flow Readers)
  • 3.1.4 Global Lateral Flow Assay Market by Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, and Drug Development & Quality Testing)
  • 3.1.5 Global Lateral Flow Assay Market by Technology (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays)
  • 3.1.6 Global Lateral Flow Assay Market by End User (Hospitals & Clinics, Diagnostic Laboratories, Home Care, Pharmaceutical & Biotechnology Companies, and Others)
  • 3.1.7 Global Lateral Flow Assay Market by Region (North America, Europe, Asia Pacific, and Rest of the World)
• 3.2 Global Lateral Flow Assay Market: Product Type Analysis
  • 3.2.1 Global Lateral Flow Assay Market by Product Type: An Overview
  • 3.2.2 Global Kits and Reagents Lateral Flow Assay Market by Value
  • 3.2.3 Global Lateral Flow Assay Readers Market by Value
• 3.3 Global Lateral Flow Assay Market: Application Analysis
  • 3.3.1 Global Lateral Flow Assay Market by Application: An Overview
  • 3.3.2 Global Clinical Testing Lateral Flow Assay Market by Value
  • 3.3.3 Global Veterinary Diagnostics Lateral Flow Assay Market by Value
  • 3.3.4 Global Food Safety & Environment Testing Lateral Flow Assay Market by Value
  • 3.3.5 Global Drug Development & Quality Testing Lateral Flow Assay Market by Value
• 3.4 Global Lateral Flow Assay Market: Technology Analysis
  • 3.4.1 Global Lateral Flow Assay Market by Technology: An Overview
  • 3.4.2 Global Sandwich Lateral Flow Assay Market by Value
  • 3.4.3 Global Competitive Lateral Flow Assay Market by Value
  • 3.4.4 Global Multiplex Detection Lateral Flow Assay Market by Value
• 3.5 Global Lateral Flow Assay Market: End User Analysis
  • 3.5.1 Global Lateral Flow Assay Market by End User: An Overview
  • 3.5.2 Global Hospitals & Clinics Lateral Flow Assay Market by Value
  • 3.5.3 Global Diagnostic Laboratories Lateral Flow Assay Market by Value
  • 3.5.4 Global Home Care Lateral Flow Assay Market by Value
  • 3.5.5 Global Pharmaceutical & Biotechnology Companies Lateral Flow Assay Market by Value
  • 3.5.6 Global Others Lateral Flow Assay Market by Value

4. Regional Market Analysis

• 4.1 North America Lateral Flow Assay Market: An Analysis
  • 4.1.1 North America Lateral Flow Assay Market: An Overview
  • 4.1.2 North America Lateral Flow Assay Market by Value
  • 4.1.3 North America Lateral Flow Assay Market by Product Type (Kits and Reagents, and Lateral Flow Readers)
  • 4.1.4 North America Lateral Flow Assay Market by Technology (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays)
  • 4.1.5 North America Lateral Flow Assay Market by Region (The US, Canada, and Mexico)
  • 4.1.6 The US Lateral Flow Assay Market by Value
  • 4.1.7 Canada Lateral Flow Assay Market by Value
  • 4.1.8 Mexico Lateral Flow Assay Market by Value
• 4.2 Europe Lateral Flow Assay Market: An Analysis
  • 4.2.1 Europe Lateral Flow Assay Market: An Overview
  • 4.2.2 Europe Lateral Flow Assay Market by Value
  • 4.2.3 Europe Lateral Flow Assay Market by Region (Germany, France, UK, Italy, Spain and Rest of Europe)
  • 4.2.4 Germany Lateral Flow Assay Market by Value
  • 4.2.5 UK Lateral Flow Assay Market by Value
  • 4.2.6 France Lateral Flow Assay Market by Value
  • 4.2.7 Italy Lateral Flow Assay Market by Value
  • 4.2.8 Spain Lateral Flow Assay Market by Value
  • 4.2.9 Rest of Europe Lateral Flow Assay Market by Value
• 4.3 Asia Pacific Lateral Flow Assay Market: An Analysis
  • 4.3.1 Asia Pacific Lateral Flow Assay Market: An Overview
  • 4.3.2 Asia Pacific Lateral Flow Assay Market by Value
  • 4.3.3 Asia Pacific Lateral Flow Assay Market by Region (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific)
  • 4.3.4 China Lateral Flow Assay Market by Value
  • 4.3.5 Japan Lateral Flow Assay Market by Value
  • 4.3.6 India Lateral Flow Assay Market by Value
  • 4.3.7 South Korea Lateral Flow Assay Market by Value
  • 4.3.8 Australia Lateral Flow Assay Market by Value
  • 4.3.9 Rest of Asia Pacific Lateral Flow Assay Market by Value
• 4.4 Rest of the World Lateral Flow Assay Market: An Analysis
  • 4.4.1 Rest of the World Lateral Flow Assay Market: An Overview
  • 4.4.2 Rest of the World Lateral Flow Assay Market by Value

5. Impact of COVID-19

• 5.1 Impact of COVID-19 on Lateral Flow Assay Market
• 5.2 Post COVID-19 Impact on Lateral Flow Assay Market

6. Market Dynamics

• 6.1 Growth Drivers
  • 6.1.1 Ageing Population
  • 6.1.2 Rising Cases Of Infectious Diseases
  • 6.1.3 Growing Adoption Of Home Based Assay Kits And Devices
  • 6.1.4 Rising Popularity Of Point-of-care Testing
• 6.2 Challenges
  • 6.2.1 Strict Regulatory Requirements Due to Inconsistent Diagnostic Results
  • 6.2.2 Increased Competition From Alternative Diagnostics Technologies
• 6.3 Market Trends
  • 6.3.1 Increasing Integration Of Artificial Intelligence (AI) And Biosensors
  • 6.3.2 Rising Digital Technology Integration
  • 6.3.3 Evolving Newer Applications Of Lateral Flow Assays
  • 6.3.4 Rising Demand For Personalized And Customized Lateral Flow Assays

7. Competitive Landscape

• 7.1 Global Lateral Flow Assay Market: Competitive Landscape

8. Company Profiles

• 8.1 F. Hoffmann-La Roche Ltd
  • 8.1.1 Business Overview
  • 8.1.2 Revenue by Operating Business
  • 8.1.3 Business Strategy
• 8.2 Siemens Healthineers AG
  • 8.2.1 Business Overview
  • 8.2.2 Operating Segments
  • 8.2.3 Business Strategy
• 8.3 Thermo Fisher Scientific Inc.
  • 8.3.1 Business Overview
  • 8.3.2 Operating Segments
  • 8.3.3 Business Strategy
• 8.4 Abbott Laboratories
  • 8.4.1 Business Overview
  • 8.4.2 Operating Segments
  • 8.4.3 Business Strategy
• 8.5 Merck KGaA (MilliporeSigma)
  • 8.5.1 Business Overview
  • 8.5.2 Operating Segments
  • 8.5.3 Business Strategy
• 8.6 Bio-Rad Laboratories, Inc.
  • 8.6.1 Business Overview
  • 8.6.2 Operating Segments
  • 8.6.3 Business Strategy
• 8.7 Becton, Dickinson and Company (BD Biosciences)
  • 8.7.1 Business Overview
  • 8.7.2 Operating Segments
  • 8.7.3 Business Strategy
• 8.8 QuidelOrtho Corporation (Quidel Corporation)
  • 8.8.1 Business Overview
  • 8.8.2 Operating Segments
  • 8.8.3 Business Strategy
• 8.9 Access Bio, Inc.
  • 8.9.1 Business Overview
• 8.10 PerkinElmer, Inc.
  • 8.10.1 Business Overview

List of Figures

• Figure 1: Lateral Flow Assay Segmentation
• Figure 2: Global Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 3: Global Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 4: Global Lateral Flow Assay Market by Product Type; 2024 (Percentage, %)
• Figure 5: Global Lateral Flow Assay Market by Application; 2024 (Percentage, %)
• Figure 6: Global Lateral Flow Assay Market by Technology; 2024 (Percentage, %)
• Figure 7: Global Lateral Flow Assay Market by End User; 2024 (Percentage, %)
• Figure 8: Global Lateral Flow Assay Market by Region; 2024 (Percentage, %)
• Figure 9: Global Kits and Reagents Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 10: Global Kits and Reagents Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 11: Global Lateral Flow Assay Readers Market by Value; 2020-2024 (US$ Billion)
• Figure 12: Global Lateral Flow Assay Readers Market by Value; 2025-2030 (US$ Billion)
• Figure 13: Global Clinical Testing Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 14: Global Clinical Testing Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 15: Global Veterinary Diagnostics Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 16: Global Veterinary Diagnostics Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 17: Global Food Safety & Environment Testing Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 18: Global Food Safety & Environment Testing Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 19: Global Drug Development & Quality Testing Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 20: Global Drug Development & Quality Testing Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 21: Global Sandwich Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 22: Global Sandwich Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 23: Global Competitive Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 24: Global Competitive Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 25: Global Multiplex Detection Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 26: Global Multiplex Detection Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 27: Global Hospitals & Clinics Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 28: Global Hospitals & Clinics Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 29: Global Diagnostic Laboratories Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 30: Global Diagnostic Laboratories Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 31: Global Home Care Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 32: Global Home Care Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 33: Global Pharmaceutical & Biotechnology Companies Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 34: Global Pharmaceutical & Biotechnology Companies Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 35: Global Others Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 36: Global Others Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 37: North America Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 38: North America Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 39: North America Lateral Flow Assay Market by Product Type; 2024 (Percentage, %)
• Figure 40: North America Lateral Flow Assay Market by Technology; 2024 (Percentage, %)
• Figure 41: North America Lateral Flow Assay Market by Region; 2024 (Percentage, %)
• Figure 42: The US Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 43: The US Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 44: Canada Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 45: Canada Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 46: Mexico Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 47: Mexico Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 48: Europe Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 49: Europe Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 50: Europe Lateral Flow Assay Market by Region; 2024 (Percentage, %)
• Figure 51: Germany Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 52: Germany Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 53: UK Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 54: UK Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 55: France Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 56: France Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 57: Italy Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 58: Italy Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 59: Spain Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 60: Spain Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 61: Rest of Europe Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 62: Rest of Europe Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 63: Asia Pacific Lateral Flow Assay Market by Value; 2020-2024 (US$ Billion)
• Figure 64: Asia Pacific Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 65: Asia Pacific Lateral Flow Assay Market by Region; 2024 (Percentage, %)
• Figure 66: China Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 67: China Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 68: Japan Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 69: Japan Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 70: India Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 71: India Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 72: South Korea Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 73: South Korea Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 74: Australia Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 75: Australia Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 76: Rest of Asia Pacific Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 77: Rest of Asia Pacific Lateral Flow Assay Market by Value; 2025-2030 (US$ Million)
• Figure 78: Rest of the World Lateral Flow Assay Market by Value; 2020-2024 (US$ Million)
• Figure 79: Rest of the World Lateral Flow Assay Market by Value; 2025-2030 (US$ Billion)
• Figure 80: Global Total Population Aging 65 and above; 2020-2023 (Million)
• Figure 81: The US Tuberculosis Cases and Disease Incidence; 2019-2022 (Units)
• Figure 82: Global Artificial Intelligence in Healthcare Market Size; 2021-2025 (US$ Billion)
• Figure 83: Global Revenue in Healthcare IoT Market; 2022-2029 (US$ Billion)
• Figure 84: F. Hoffmann-La Roche Ltd Revenue by Operating Business; 2024 (Percentage, %)
• Figure 85: Siemens Healthineers AG Revenue by Segment; 2024 (Percentage, %)
• Figure 86: Thermo Fisher Scientific Inc. Revenues by Segment; 2023 (Percentage, %)
• Figure 87: Abbott Laboratories Net Sales by Segment; 2023 (Percentage, %)
• Figure 88: Merck KGaA Net Sales by Reportable Segment; 2023 (Percentage, %)
• Figure 89: Bio-Rad Laboratories, Inc. Net Sales by Segments; 2023 (Percentage, %)
• Figure 90: Becton, Dickinson and Company Revenue by Segment; 2024 (Percentage, %)
• Figure 91: QuidelOrtho Corporation Revenue by Operating Segment; 2023 (Percentage, %)